Podcast: Navigating biologics – when to start, when to switch and how to handle the data: a guide for advanced trainees

Thursday, 24 Jun 2021

Today we’re incredibly excited to announce our latest offering: the limbic podcast for rheumatology advanced trainees, a six part series focussing on how to tackle some of the most challenging areas of practice.

Hosted by Sunalie Silva, clinical news reporter and editor of the limbic podcast, the first episode is a conversation with Dr David Liew and Dr Tina Racunica about biologics.

In this episode David and Tina discuss what you need to know about considering biologics in special populations particularly in patients with cancer, the new JAK inhibitors and where they fit into treatment regimens, when to switch agents and how to balance clinical trial data among different agents to make treatment decisions.

You can listen to the episode right now.

Over the past year, the limbic has been collaborating with the Australian Rheumatology Association to seek out some of the country’s most inspiring and thought provoking rheumatologists to share what they’ve learned about working in some of the most fascinating – and complex – areas of the profession. Each episode takes a deep dive into a therapy, a sub specialty or an area where rheumatology and society intersect. Featuring conversations with experts from the ARA including including Dr Sam Whittle,  Dr Tony Sammel, Dr Emma Guymer, Dr Daman Langguth, Dr Richard Kwiatek and more they’ll go behind the trainee curriculum to share the reality of practice.


This series is a collaboration with the Australian Rheumatology Association and the limbic. New episodes of season one will be drop every week over the next four weeks, so be sure to follow the limbic podcast in your favourite podcast app so you don’t miss out. You can also visit us at the limbic to get all the latest rheumatology news delivered to your email.



Already a member?

Login to keep reading.

Email me a login link

© 2022 the limbic